The Epstein-Barr virus is one of the most common and persistent human viruses in the world, according to the CDC.

Scientists at The Wistar Institute have discovered that a class of FDA-approved cancer drugs known as PARP1 inhibitors can effectively combat Epstein-Barr virus (EBV)-driven lymphomas. The findings, ...

Scientists at The Wistar Institute have discovered how a key protein from the Epstein-Barr virus (EBV), EBNA-LP, ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

A rare case of Epstein-Barr virus-induced Bell palsy in an 18-year-old highlights the need for EBV testing in sudden facial ...

Head and neck cancers (HNCs) form a diverse group of malignant tumors originating in the upper aerodigestive tract, ranking ...